The Schizophrenia and Bipolar Disorder Research Program, led by Dr. Öngür, was founded in 2006 and has grown greatly in scope and depth since then. The long-term goal is to develop new treatments for patients in the Division of Psychotic Disorders, including medicines, computer programs, and early intervention strategies.

Dr. Öngür’s research proceeds on two fronts: clinical course and neurobiology. The clinical course of psychotic disorders are variable and difficult to predict. A deeper understanding of the factors that determine long-term outcomes for individual patients would be valuable in tailoring treatments and deploying scarce resources where they are most needed.